Regulatory environment for clinical research: Recent past and expected future

Area of Science:

• Clinical research policy
• Regulatory affairs in India
• Patient safety guidelines

Background:

• India's regulatory landscape for clinical research has undergone significant policy and guideline revisions.
• Initial changes prioritized patient safety, creating a more challenging environment for research conduct.
• Recent evolution shows a positive shift, balancing patient safety with support for research.

Purpose of the Study:

• To analyze the recent evolution of clinical research regulations in India.
• To assess the impact of regulatory changes on patient safety and research environment.
• To project the future implications for accessing innovative medicines in India.

Main Methods:

• Review of updated policies and guidelines governing clinical research in India.
• Analysis of regulatory shifts concerning patient safety and research support.
• Assessment of the anticipated impact on the introduction of new medicines.

Main Results:

• Numerous policy and guideline updates have occurred in Indian clinical research.
• The regulatory environment initially became challenging due to a strong focus on patient safety.
• Recent regulatory evolution demonstrates a positive trend, supporting clinical research while maintaining safety.

Conclusions:

• Indian clinical research regulations have evolved positively, balancing patient safety and research support.
• These advancements are expected to expedite the availability of novel therapeutics for Indian patients.
• The revised regulatory framework is poised to enhance India's role in global clinical research.